EUVIMEDEUVIMED entdecken
Crossref

Nonsentinel lymph node metastases in cases of micrometastasis detected by sentinel lymph node biopsy after neoadjuvant chemotherapy

Dong Seung Shin iD, Jai Min Ryu, Se Kyung Lee iD, Jonghan Yu, Jeong Eon Lee, Seok Won Kim, Seok Jin Nam, Byung Joo Chae

Cancer · 2025-01 · 131 (1)

DOI: 10.1002/cncr.35567 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer, online erschienen am 21.09.2024. Verfasst von Dong Seung Shin und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Breast Surgery, Department of Surgery, Samsung Medical Center, Sungkyunkwan University of Medicine, Seoul, South Korea. Hauptthemen laut MEDLINE: Sentinel Lymph Node Biopsy, Neoplasm Micrometastasis, Neoadjuvant Therapy, Breast Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 27 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

There is a clinical need to omit axillary lymph node dissection (ALND) when residual disease in sentinel lymph nodes (SLNs) is low after neoadjuvant chemotherapy (NAC). This study aimed to clarify the relationship between micrometastasis in SLNs after NAC and additional non‐SLN metastases by analyzing SLN biopsy results followed by ALND.

Methods

This retrospective study reviewed clinical records of patients who underwent breast cancer surgery between January 2010 and June 2022 after NAC at Samsung Medical Center. Of 3944 patients, 806 underwent SLN biopsy followed by ALND. Intraoperative frozen SLN biopsy results were examined, including the number and size of metastases in SLNs, and further investigated the number of additional non‐SLN metastases.

Results

Among the 806 patients, 95 (11.8%) had micrometastasis on SLNs in frozen sections, of which 89 (93.7%) had clinically node‐positive (cN1‐3) breast cancer before NAC. Twenty‐three patients (24.2%) exhibited positive additional non‐SLNs after ALND. The presence of lymphovascular invasion (vs. absence; odds ratio [OR] = 4.02, p = .0151) and having two or more SLNs with micrometastasis (vs. a positive SLN; OR = 3.65, p = .0301) were significantly associated with additional non‐SLN metastases. Tumor subtypes and breast pathological complete response after NAC showed no correlation with the additional non‐SLN metastases.

Conclusion

The study identified a 24.2% possibility of additional non‐SLN metastasis if micrometastases was detected in the SLN after NAC. This rate is significant, indicating that ALND cannot be omitted if low volume residual disease, such as micrometastasis, is identified in the SLN after NAC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sentinel Lymph Node BiopsyNeoplasm MicrometastasisNeoadjuvant TherapyBreast NeoplasmsLymphatic MetastasisHumansFemaleMiddle AgedRetrospective StudiesAgedAdultAxillaLymph Node ExcisionSentinel Lymph NodeLymph Nodes

Stichwörter der Autor:innen

axillary lymph node dissectionbreast cancermicrometastasisneoadjuvant therapysentinel lymph node

Autor:innen und Institutionen

  • Division of Breast Surgery, Department of Surgery, Samsung Medical Center, Sungkyunkwan University of Medicine, Seoul, South Korea.

ORCID-Profile: Dong Seung Shin, Se Kyung Lee

Zitieren

APA

Shin, D. S., Ryu, J. M., Lee, S. K., Yu, J., Lee, J. E., Kim, S. W., Nam, S. J., & Chae, B. J. (2025). Nonsentinel lymph node metastases in cases of micrometastasis detected by sentinel lymph node biopsy after neoadjuvant chemotherapy. Cancer, 131(1). https://doi.org/10.1002/cncr.35567

Vancouver

Shin DS, Ryu JM, Lee SK, Yu J, Lee JE, Kim SW, et al. Nonsentinel lymph node metastases in cases of micrometastasis detected by sentinel lymph node biopsy after neoadjuvant chemotherapy. Cancer. 2025;131(1). doi:10.1002/cncr.35567

BibTeX
@article{Shin2025,
  author = {Shin, Dong Seung and Ryu, Jai Min and Lee, Se Kyung and Yu, Jonghan and Lee, Jeong Eon and Kim, Seok Won and Nam, Seok Jin and Chae, Byung Joo},
  title = {Nonsentinel lymph node metastases in cases of micrometastasis detected by sentinel lymph node biopsy after neoadjuvant chemotherapy},
  journal = {Cancer},
  year = {2025},
  volume = {131},
  number = {1},
  doi = {10.1002/cncr.35567}
}
Kostenlos starten →